68Ga-PSMA PET/CT for Prostate Cancer

Phase-Based Progress Estimates
Royal University Hospital, Saskatoon, CanadaProstate Cancer68Ga-PSMA PET/CT - Drug
18 - 100
What conditions do you have?

Study Summary

This trial is testing a new way to look for prostate cancer using a PET/CT scan. The study is open label, which means that participants and doctors will know which treatment is being given. The study will follow participants for up to 6 months to see how well the PET/CT scan works.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 6 months

6 months
Sensitivity and specificity of 68Ga-PSMA-11 PET/CT compared to that of CT alone and bone scan in two different cohorts of prostrate cancer patients.
Day 14
The secondary endpoint is the number of adverse events, both immediate and delayed.

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

High Risk Prostate Cancer
1 of 2
Biochemical Reoccurrence
1 of 2

Experimental Treatment

500 Total Participants · 2 Treatment Groups

Primary Treatment: 68Ga-PSMA PET/CT · No Placebo Group · Phase 3

High Risk Prostate Cancer
Experimental Group · 1 Intervention: 68Ga-PSMA PET/CT · Intervention Types: Drug
Biochemical Reoccurrence
Experimental Group · 1 Intervention: 68Ga-PSMA PET/CT · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

University of SaskatchewanLead Sponsor
239 Previous Clinical Trials
89,409 Total Patients Enrolled
Rajan RakhejaPrincipal InvestigatorUniversity of Saskatchewan

Eligibility Criteria

Age 18 - 100 · Male Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Rewritten Criterion: You are a male.

Frequently Asked Questions

Are there any open positions in this clinical trial for new patients?

"This clinical trial is actively recruiting patients, according to the latest information on clinicaltrials.gov. The listing for this study was first posted on December 9th 2020 and updated on December 22nd of the same year." - Anonymous Online Contributor

Unverified Answer

Does this research allow for volunteers who are still in their twenties?

"Eligibility requirements for this clinical trial state that patients must be aged 18 to 100. Out of the 80 trials available for minors, and 1358 trials available for senior citizens, this is the only one that includes them both." - Anonymous Online Contributor

Unverified Answer

For whom is this trial looking for participants?

"Eligibility requirements for this prostate cancer trial include being between 18 and 100 years old. So far, 500 people have signed up to participate in the study." - Anonymous Online Contributor

Unverified Answer

What risks are associated with 68Ga-PSMA PET/CT?

"There is available clinical data that suggests 68Ga-PSMA PET/CT is safe, giving it a score of 3." - Anonymous Online Contributor

Unverified Answer

How many test subjects are a part of this clinical research?

"That is correct. The clinical trial was originally posted on 12/9/2020 and was most recently edited on 12/22/2020. The study is looking for 500 patients at 1 sites." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.